Selected article for: "cell line and proliferation inhibit"
Author: Li, Lv; Dai, Hong-Juan; Ye, Mao; Wang, Shu-Ling; Xiao, Xiao-Juan; Zheng, Jie; Chen, Hui-Yong; Luo, Yu-hao; Liu, Jing
Title: Lycorine induces cell-cycle arrest in the G0/G1 phase in K562 cells via HDAC inhibition
  • Document date: 2012_11_23
    • ID: 13amcxh2_4
    Snippet: In this study, we further reveal that lycorine can inhibit proliferation of the human CML cell line K562. Analysis of HDAC activity shows that lycroine decreases HDAC enzymatic activities in K562 cells in a dosedependent manner. To determine the effect of HDAC inhibition, we evaluate the cell cycle distribution after lycorine treatment. We show that lycorine inhibits the proliferation of K562 cells through G0/G1 phase arrest, which is mediated by.....
    Document: In this study, we further reveal that lycorine can inhibit proliferation of the human CML cell line K562. Analysis of HDAC activity shows that lycroine decreases HDAC enzymatic activities in K562 cells in a dosedependent manner. To determine the effect of HDAC inhibition, we evaluate the cell cycle distribution after lycorine treatment. We show that lycorine inhibits the proliferation of K562 cells through G0/G1 phase arrest, which is mediated by the regulation of G1-related proteins. After lycorine treatment, cyclin D1 and cyclindependent kinase 4 (CDK4) expressions are inhibited and retinoblastoma protein (pRB) phosphorylation is reduced. Lycorine treatment also significantly upregulates the expression of p53 and its target gene product, p21. These results suggest that inhibition of HDAC activity is responsible for at least part of the induction of G1 cell-cycle arrest of K562 cells by lycorine.

    Search related documents:
    Co phrase search for related documents
    • cell cycle and enzymatic activity: 1, 2, 3, 4, 5
    • cell cycle and G0 G1 phase arrest: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21
    • cell cycle and HDAC activity: 1, 2, 3, 4
    • cell cycle and HDAC activity inhibition: 1, 2, 3
    • cell cycle and HDAC inhibition: 1, 2, 3
    • cell cycle and lycorine treatment: 1, 2, 3, 4
    • cell cycle and phase arrest: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell cycle and pRB phosphorylation: 1, 2, 3
    • cell cycle and protein regulation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • cell cycle and retinoblastoma protein: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • cell cycle arrest and enzymatic activity: 1, 2
    • cell cycle arrest and HDAC activity: 1, 2, 3
    • cell cycle arrest and HDAC activity inhibition: 1, 2, 3
    • cell cycle arrest and HDAC inhibition: 1, 2, 3
    • cell cycle arrest and lycorine treatment: 1, 2, 3, 4
    • cell cycle arrest and phase arrest: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • cell cycle arrest and pRB phosphorylation: 1, 2
    • cell cycle arrest and protein regulation: 1, 2
    • cell cycle arrest and retinoblastoma protein: 1, 2, 3, 4, 5